All data are based on the daily closing price as of April 10, 2026
b
BioNote
377740.KO
3.35 USD
0.02
+0.60%
Overview
Last close
3.35 usd
Market cap
338.89M usd
52 week high
4.47 usd
52 week low
2.83 usd
Target price
3.84 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
4.248
Price/Book Value
0.3518
Enterprise Value
162.05M usd
EV/Revenue
2.1474
EV/EBITDA
1.1631
Key financials
Revenue TTM
79.69M usd
Gross Profit TTM
44.23M usd
EBITDA TTM
17.54M usd
Earnings per Share
N/A usd
Dividend
0.15 usd
Total assets
1.08B usd
Net debt
N/A usd
About
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.